COVID-19 Resources for Blood Donor Centers
Developed with input from federal regulators, AABB’s regulatory resources are clear, user-friendly tools that help blood centers and transfusion services protect donor and patient safety at each step in the transfusion chain.
Reporting Fatalities Related to Blood Transfusion and Donation to FDA
REGULATORY UPDATE: FDA Expects IRA Final Guidance Before End of PHE
February 03, 2023
Peter Marks to Join Thursday Hot Topic Discussion on Individual Risk Assessment
February 01, 2023
REGULATORY UPDATE: FDA Releases 2023 Guidance Agenda
January 31, 2023